Poster Section News Today

IND-enabling studies expected to begin mid-2024WALTHAM, Mass. and BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced new preclinical data from the Company’s potent, selective, CNS-penetrant ErbB2 inhibitor program. The data are being presented in a poster session at the American Association for Cancer Research (AACR) 2024 Annual Meeti...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that preclinical data on multiple novel bispecific antibodies as well as antibody-drug-conjugates (ADCs) from its oncology pipeline are presented at the American Association for Cancer Research (AACR) Ann...

/PRNewswire/ -- Laekna (2105.HK) announced that the company has presented two internally-discovered preclinical candidates, in addition to a poster...

Tärkeimmät ajankohtaiset talousuutiset, pörssikurssit ja kattavat sijoittajapalvelut löydät Kauppalehdestä.

Findings support the ongoing development of BBI-355, a novel, oral, selective inhibitor of checkpoint kinase 1 in Phase 1/2 development, as a differentiated treatment approach for ecDNA-enabled...

/PRNewswire/ -- Serum Detect, Inc., a cancer diagnostics company advancing new technologies for early detection of cancer, today announced the presentation of...

WATERTOWN, Mass., April 08, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, presented a poster today at

WATERTOWN, Mass. and GOSSELIES, Belgium, April 07, 2024 -- iTeos Therapeutics, Inc. , a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of...

WATERTOWN, Mass. and GOSSELIES, Belgium, April 07, 2024 -- iTeos Therapeutics, Inc. , a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of...

Berlin, Germany, 4 April 2024 - Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announces that it will be presenting a poster, demonstrating its new findings on the discovery of novel macrocyclic...